Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.35 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1751084 | 0.72 | HRH3 (0.40) | HRH3CHRNB4CHRNA3SPHK2SPHK1 | |
| SCHEMBL27368213 | 0.71 | KDM4E (0.40) | HRH3SPHK2SPHK1KDM4EALDH1A1 | |
| SCHEMBL13640459 | 0.67 | KMT2A (0.41) | TDP1 | |
| SCHEMBL15939331 | 0.64 | ALDH1A1 (0.57) | TDP1CHRNB4CHRNA3KDM4EALDH1A1 | |
| SCHEMBL7111287 | 0.64 | TERT (0.43) | FAAHKDM4EALDH1A1 | |
| SCHEMBL2300940 | 0.63 | LTA4H (0.53) | HRH3KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL12486958 | 0.63 | LTA4H (0.58) | HRH3KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL3154476 | 0.61 | HRH3 (0.57) | HRH3KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL10516616 | 0.61 | MAPT (0.41) | TDP1HRH3KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL1372851 | 0.61 | HRH3 (0.66) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1412350-A1 | PAROXETINE ISETHIONATE SALT, PROCESS OF PREPARATION AND USE IN THE TREATMENT OF DEPRESSION | Spurcourt Limited (GB) | 2004-04-28 | — | — | EP | disclosed |
| EP-0991408-A4 | NOVEL PROCESS FOR MANUFACTURING PAROXETINE SOLID DISPERSIONS | ENDO PHARMACEUTICALS INC (US) | 2003-07-09 | — | — | EP | disclosed |
| WO-2003020717-A1 | PAROXETINE ISETHIONATE SALT, PROCESS OF PREPARATION AND USE IN THE TREATMENT OF DEPRESSION | SPURCOURT LIMITED (GB) | 2003-03-13 | — | — | WO | disclosed |
| EP-1075263-A1 | AQUEOUS PROCESS FOR MANUFACTURING PAROXETINE SOLID DISPERSIONS | Endo Pharmaceuticals Inc. (US) | 2001-02-14 | — | — | EP | disclosed |
| EP-0991408-A1 | NOVEL PROCESS FOR MANUFACTURING PAROXETINE SOLID DISPERSIONS | Endo Pharmaceuticals Inc. (US) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999056751-A1 | AQUEOUS PROCESS FOR MANUFACTURING PAROXETINE SOLID DISPERSIONS | ENDO PHARMACEUTICALS INC. (US) | 1999-11-11 | — | — | WO | disclosed |
| WO-1999000131-A1 | NOVEL PROCESS FOR MANUFACTURING PAROXETINE SOLID DISPERSIONS | ENDO PHARMACEUTICALS INC. (US) | 1999-01-07 | — | — | WO | disclosed |